Mass Spectrometric Analysis of the Active Site Tryptic Peptide of Recombinant O6-Methylguanine-DNA Methyltransferase Following Incubation with Human Colorectal DNA Reveals the Presence of an O6-Alkylguanine Adductome
O-6-methylguanine-DNA methyltransferase
DNA methyltransferase
DOI:
10.1021/acs.chemrestox.3c00207
Publication Date:
2023-11-20T18:11:26Z
AUTHORS (14)
ABSTRACT
Human exposure to DNA alkylating agents is poorly characterized, partly because only a limited range of specific alkyl adducts have been quantified. The human repair protein, O6-methylguanine O6-methyltransferase (MGMT), irreversibly transfers the group from O6-alkylguanines (O6-alkGs) an acceptor cysteine, allowing simultaneous detection multiple O6-alkG modifications in by mass spectrometric analysis MGMT active site peptide (ASP). Recombinant was incubated with oligodeoxyribonucleotides (ODNs) containing different O6-alkGs, Temozolomide-methylated calf thymus (Me-CT-DNA), or colorectal known O6-MethylG (O6-MeG) levels. It digested trypsin, and ASPs were detected quantified matrix-assisted laser desorption/ionization-time-of-flight spectrometry. S-methyl, S-ethyl, S-propyl, S-hydroxyethyl, S-carboxymethyl, S-benzyl, S-pyridyloxobutyl cysteine groups incubating ODNs corresponding O6-alkGs. LOQ S-methylcysteine after incubation Me-CT-DNA <0.05 pmol O6-MeG per mg CT-DNA. Incubation produced at levels that correlated those determined previously HPLC-radioimmunoassay (r2 = 0.74; p 0.014). O6-CMG, putative O6-hydroxyethylG adduct, other potential unidentified substrates also samples. This novel approach identification quantitation O6-alkGs has revealed existence adductome remains be fully characterized. methodology establishes platform for characterizing and, given mutagenic can provide mechanistic information about cancer pathogenesis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....